Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Maria Yeray Rodriguez Garcés"'
Autor:
Laura Fernández Madrigal, Olalla Montero Pérez, Maria Yeray Rodriguez Garcés, Ángel Inoriza Rueda, Francisco Javier Martínez Marcos
Publikováno v:
Journal of Oncology Pharmacy Practice. 28:1664-1670
Introduction The treatment of non-small cell lung cancer (NSCLC) has profoundly changed on account of the arrival of new therapies, like immunotherapy. Within this group of drugs, those aimed at the programmed cell death-1 or programmed cell death li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd3af21143773c640633ac7b30210b9a
https://doi.org/10.1177/10781552221077974
https://doi.org/10.1177/10781552221077974
Autor:
Maria Yeray Rodriguez Garcés, Loreto Domínguez Senín, María Amor Urbano, Victoria Aviñó Tarazona
Publikováno v:
Journal of Clinical Oncology. 40:e15564-e15564
e15564 Background: TAS-102 (trifluridine - tipiracil) increases the survival of patients with metastatic colorectal cancer (mCRC) in 3rd or successive lines based on the results in overall survival (OS) of the phase 2 trial by Yoshino T et al and of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46ba4f282805c24d0e45c40f9517b8e8
https://doi.org/10.1200/jco.2022.40.16_suppl.e15564
https://doi.org/10.1200/jco.2022.40.16_suppl.e15564
Autor:
Loreto Domínguez Senín, David Morales Pancorbo, María Yeray Rodríguez Garcés, María Dolores Santos-Rubio, Juan Bayo Calero
Publikováno v:
Current Oncology, Vol 31, Iss 1, Pp 250-259 (2024)
Objective: We aimed to evaluate the use of CDK4/6 inhibitors as a risk factor for medication-related osteonecrosis of the jaw (MRONJ) in a cohort of patients with metastatic breast cancer treated with denosumab. Methods: This was a multicentre, retro
Externí odkaz:
https://doaj.org/article/3c73cc0bf2b1469588603ae7d5ee3824